2024 Annual Meeting | C106 - Autoimmune Neurology: Paraneoplastic

Date Tuesday 04/16/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Marianna Spatola, MD, PhD

Topic(s) Autoimmune Neurology

Learning Objectives Participants should learn to recognize the clinical features of paraneoplastic neurologic disorders of the CNS, know the cancer association, the associated neuronal antibodies targeting intracellular antigens, and the techniques for their detection. This course will also illustrate how neuropathological findings can help diagnosis and will provide attendees with an overview of the experimental models of autoimmune paraneoplastic neurologic disorders and their therapeutic implications.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
07:00 AM - 07:35 AM MDT	Speaker	Overview of Paraneoplastic Syndromes and Diagnostic Tips Marianna Spatola, MD, PhD
07:35 AM - 08:10 AM MDT	Speaker	Neuropathological Findings and Implications for Diagnosis Romana Hoeftberger
08:10 AM - 08:45 AM MDT	Speaker	Pathogenic Mechanisms: Immunological Bases of Paraneoplastic Syndromes and Therapeutic Implications Roland Liblau
08:45 AM - 09:00 AM MDT	Q&A	Questions & Answers Marianna Spatola, MD, PhD, Roland Liblau, Romana Hoeftberger

Faculty Disclosures
Roland Liblau	Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-genzyme. Roland Liblau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Servier. Roland Liblau has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Immunology. The institution of Roland Liblau has received research support from Roche. The institution of Roland Liblau has received research support from ARSEP. The institution of Roland Liblau has received research support from Fondation pour la Recherche Médicale. The institution of Roland Liblau has received research support from Population Bio UK, Inc. The institution of Roland Liblau has received research support from ANR.
Marianna Spatola, MD, PhD	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation.
Romana Hoeftberger	Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun and UCB Biopharma.

��ɫ��

��ɫ��